News

Credo buys Affineon, rebrands as Pajama.ai to kill doctors' "pajama time

What's the deal? Credo Health has acquired Affineon HealthDealroom has a profile for this one. Try Dealroom → and relaunched as Pajama.ai, an AI assistant that preps patient charts, handles lab results, and processes prescription renewals. The company says the combined platform gives each doctor back about 40 hours a month. Terms were not disclosed.

Why the name? "Pajama time" is the after-hours EHR work doctors do at home — reviewing charts, signing off on labs, approving refills. One in three family physicians still spends three or more hours a day on after-hours documentation, according to 2026 federal data.

What each side brings. Credo's AI retrieves and assembles complete patient records, then surfaces clinical insights such as care gaps and overdue screenings. Affineon adds an "actionability layer" that completes the work across lab results, prescription renewals, and inbox messages.

The numbers. The combined company serves more than 200 clinical groups, 3,000 doctors, and 5 million patients. Pajama runs inside existing EHR workflows as a monthly subscription, automating 40% to 60% of inbox messages and cutting chart prep by three to five minutes per patient. Affineon had raised $5 million before the deal.

The hire. Carm Huntress, who previously founded Arrive Health, continues as CEO. Affineon CEO Evan Grossman — a nine-year athenahealth veteran who helped build Zus Health — joins as chief product officer and will lead the combined roadmap.

What they're saying. "Every doctor I know has a version of the same story: dinner, the kids go to bed, and then the laptop comes out," said Huntress. Grossman added that existing Affineon customers "won't see anything change in the tools they rely on today. They'll just have more of their day back."

The signal: Much of healthcare AI spending has centered on ambient scribes, but vendors including Abridge, Ambience, and Suki are pushing into coding and operational workflows as the market moves past note-taking. The catch: research warns scribe tools can cut EHR time without reducing after-hours work. For Pajama, the test is whether it can show measurable time savings in real clinics — not just ship another AI product.

Read more: prnewswire.com

Image credit: Pajama.ai, via PR Newswire

More top stories